methamphetamine and Nervous System Disorders

methamphetamine has been researched along with Nervous System Disorders in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19902 (8.33)18.7374
1990's13 (54.17)18.2507
2000's4 (16.67)29.6817
2010's4 (16.67)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
De Luca, MA; Simola, N1
Ceccatelli, S1
Brooks, DM; Hutchinson, J; Kothiwal, AS; Poulsen, AJ; Poulsen, DJ; Rau, TF; Rhoderick, JF; Rova, AR1
Donlon, M; Kelly, JP; McDonnell-Dowling, K1
Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; QuiƱones-Hinojosa, A; Shah, A1
Kita, T; Nakashima, T; Wagner, GC1
D'Astous, M; Di Paolo, T; Dluzen, DE; Gajjar, TM1
de Almeida, SM; Ellis, RJ; Joseph, J1
Booze, RM; Ferris, MJ; Mactutus, CF1
Seiden, LS; Vosmer, G1
Cadet, JL; Epstein, C; Hirata, H; Ladenheim, B; Rothman, RB1
Koyama, T; Muraki, A; Ohmori, T; Yamashita, I1
Stephans, SE; Yamamoto, BK1
Sabol, KE; Seiden, LS1
Eisch, AJ; Marshall, JF; O'Dell, SJ1
CastaƱeda, E; Friedman, SD; Hodge, GK1
Katz, JL; Ricaurte, GA; Steele, TD1
Wagner, GC; Walsh, SL2
Fuller, RW; Hemrick-Luecke, SK; Ornstein, PL1
Black, CK; Schmidt, CJ; Taylor, VL1
Marshall, JF; O'Dell, SJ; Weihmuller, FB1
Gibb, JW; Hanson, GR; Johnson, M1
De Vito, MJ; Wagner, GC1

Reviews

6 review(s) available for methamphetamine and Nervous System Disorders

ArticleYear
Mechanisms of neurotoxicity and implications for neurological disorders.
    Journal of internal medicine, 2013, Volume: 273, Issue:5

    Topics: Anti-HIV Agents; Central Nervous System Stimulants; Congresses as Topic; Hazardous Substances; Humans; Manganese; Methamphetamine; Nervous System Diseases; Neurotoxicity Syndromes; Neurotoxins; Parkinson Disease; Receptors, Dopamine; Risk Factors; Trace Elements

2013
Animal models of neurological disease.
    Advances in experimental medicine and biology, 2010, Volume: 671

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents

2010
Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.
    Journal of pharmacological sciences, 2003, Volume: 92, Issue:3

    Topics: Animals; Biogenic Monoamines; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Oxidative Stress; Research Design

2003
NeuroAIDS in Brazil.
    Journal of neurovirology, 2007, Volume: 13, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Animals; Anti-Retroviral Agents; Brain; Brazil; Central Nervous System Stimulants; Cognition; Cognition Disorders; Comorbidity; Congresses as Topic; Developing Countries; Drug Resistance, Viral; Genetic Variation; Global Health; Government Programs; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Methamphetamine; Nervous System Diseases; Neuropsychological Tests; Somatostatin

2007
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.
    Neuroscience and biobehavioral reviews, 2008, Volume: 32, Issue:5

    Topics: Animals; Brain; Cocaine; Dopamine; HIV; HIV Infections; Humans; Methamphetamine; Nervous System Diseases; Neural Pathways; Neurotoxicity Syndromes; Neurotoxins; Substance-Related Disorders

2008
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.
    NIDA research monograph, 1996, Volume: 163

    Topics: Animals; Central Nervous System Stimulants; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats

1996

Other Studies

18 other study(ies) available for methamphetamine and Nervous System Disorders

ArticleYear
Editorial of special issue - Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects.
    Experimental neurology, 2022, Volume: 347

    Topics: Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Psychotropic Drugs; Treatment Outcome

2022
Administration of low dose methamphetamine 12 h after a severe traumatic brain injury prevents neurological dysfunction and cognitive impairment in rats.
    Experimental neurology, 2014, Volume: 253

    Topics: Animals; Brain Injuries; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Humans; Male; Maze Learning; Methamphetamine; Nervous System Diseases; Neurofilament Proteins; Neurons; Rats; Rats, Wistar; Space Perception; Time Factors

2014
Methamphetamine exposure during pregnancy at pharmacological doses produces neurodevelopmental and behavioural effects in rat offspring.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2014, Volume: 35

    Topics: Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Female; Male; Mental Disorders; Methamphetamine; Nervous System Diseases; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley

2014
Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
    Neuroendocrinology, 2004, Volume: 79, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Chromatography, High Pressure Liquid; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Interactions; Estradiol; Female; In Situ Hybridization; Iodine Isotopes; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neostriatum; Nerve Tissue Proteins; Nervous System Diseases; Neuroprotective Agents; Ovariectomy; Protein Binding; RNA, Messenger; Substantia Nigra; Time Factors

2004
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 21, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydroxydopamines; Male; Methamphetamine; Nervous System Diseases; Oxidopamine; Rats; Rats, Inbred Strains

1984
Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals.
    Brain research, 1995, Apr-24, Volume: 677, Issue:2

    Topics: Animals; Autoradiography; Brain; Free Radicals; Male; Methamphetamine; Mice; Mice, Transgenic; Nervous System Diseases; Presynaptic Terminals; Serotonin; Superoxide Dismutase

1995
Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions.
    Journal of neural transmission. General section, 1993, Volume: 92, Issue:2-3

    Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dizocilpine Maleate; Dopamine; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methylaspartate; Nervous System Diseases; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin

1993
Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Synapse (New York, N.Y.), 1994, Volume: 17, Issue:3

    Topics: Animals; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Extracellular Space; Glutamic Acid; Haloperidol; Male; Methamphetamine; Microdialysis; Nervous System Diseases; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley

1994
Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine.
    Synapse (New York, N.Y.), 1996, Volume: 22, Issue:3

    Topics: Animals; Autoradiography; Carrier Proteins; Caudate Nucleus; Cerebral Cortex; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glutamic Acid; Image Processing, Computer-Assisted; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Neostriatum; Nerve Tissue Proteins; Nervous System Diseases; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1996
Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:1

    Topics: Animals; Behavior, Animal; Biogenic Monoamines; Central Nervous System Stimulants; Male; Maze Learning; Methamphetamine; Nervous System Diseases; Orientation; Psychomotor Performance; Rats

1998
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Brain research, 1992, Sep-04, Volume: 589, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Hallucinogens; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship

1992
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2

    Topics: Animals; Avoidance Learning; Disease Models, Animal; Dopamine; Fenfluramine; Levodopa; Male; Methamphetamine; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Serotonin

1992
Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
    Neuropharmacology, 1992, Volume: 31, Issue:10

    Topics: Amino Acids; Amphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Iprindole; Isoquinolines; Male; Methamphetamine; Mice; Nervous System Diseases; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1992
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    European journal of pharmacology, 1991, Oct-02, Volume: 203, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin

1991
Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
    Brain research, 1991, Nov-15, Volume: 564, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Male; Methamphetamine; Nervous System Diseases; Putamen; Rats; Rats, Inbred Strains

1991
Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 1991, Volume: 9, Issue:2

    Topics: Aging; Animals; Clorgyline; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nervous System Diseases; Neurons; Selegiline

1991
Neurochemical basis of neurotoxicity.
    Neurotoxicology, 1990,Summer, Volume: 11, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Monoamines; Designer Drugs; Dopamine; Glutamates; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Nervous System Diseases; Serotonin

1990
Functional consequences following methamphetamine-induced neuronal damage.
    Psychopharmacology, 1989, Volume: 97, Issue:4

    Topics: Animals; Behavior, Animal; Brain Chemistry; Dopamine; Drinking; Male; Methamphetamine; Nervous System Diseases; Rats; Rats, Inbred Strains; Serotonin

1989